Please login to the form below
Shingrix
This page shows the latest Shingrix news and features for those working in and with pharma, biotech and healthcare.
GSK gets maintenance indication for Trelegy
Among GSK’s other critical growth products shingles vaccine Shingrix made £110m in the first quarter - stronger than expected - while its HIV portfolio grew 6% to £1.05bn, which some analysts
Latest news
-
Gilead’s triple HIV drug approval prompts GSK lawsuit
vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy - as it faces the imminent threat of generic competition to its big-selling respiratory drug Advair (salmeterol ... Shingrix was approved in
-
GSK’s ViiV gets US okay for two-drug HIV regimen
It’s an important drug for GSK, and along with shingles vaccine Shingrix and recently-approved triple therapy for chronic obstructive pulmonary disorder (COPD) Trelegy.
-
GSK’s R&D head Vallance departs, possibly for government role
She also said that it must make the most of near-term product launches - Shingrix shingles vaccine, dolutegravir-based HIV products and its triple therapy for chronic obstructive pulmonary disorder - to
-
CDC backs GSK’s Shingrix over Merck & Co’s Zostavax
CDC backs GSK’ s Shingrix over Merck &Co’ s Zostavax. US advisors recommend GSK's shingle vaccine be used instead of Merck's rival product. ... Prospects for GlaxoSmithKline’s new shingle vaccine Shingrix have been raised after US advisors
-
GSK’s shingles vaccine Shingrix claims US approval
GSK’ s shingles vaccine Shingrix claims US approval. Becomes first alternative to Merck &Co’s Zostavax. ... In trials however Shingrix has shown improved protection against shingles particularly in older people according to GSK, which says its
More from news
Approximately 8 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
-
Senior Medical Writer
-
Great salary and bebefits
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Account Manager – Med Comms – London
-
Salary TBC
-
Senior Programme Executive
-
Salary TBC
-
Scientific Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
Subscribe to our email news alerts
PMHub
SpotMe
SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
